Muhammad Amir Khan

Experience

• 

  HelmholtzZentrum München

  Mar 2007 - Oct 2011

  Postdoctoral Research Scientist

  Analysis of FoxO 1/3/4 conditional Knockout mice to investigate FoxO transcription factors role in stem cells homeostasis in the subgranular zone of the adult mouse hippocampus.Analysis of interaction between FoxO transcription factors and components of the Notch-pathway.Expression analysis of Far upstream element binding protein 3 (FUBP3) in mice hippocampal subgranular zone.

• 

  DKFZ German Cancer Research Center

  Nov 2011 - Apr 2017

  Postdoctoral Research Scientist

  Tracing of NR2E1 expressing brain tumor stem cells in a somatic glioblastoma mouse model.Tracing of tumor non-stem cells in a somatic glioblastoma mouse model.Single cell RNA sequencing of tumor stem cells and non-stem cells from somatic glioblastoma mouse model. Single cell RNA sequencing of stem cells from adult and aged mice Sub-ventricular zone.

• 

  GPM Deutsche Gesellschaft für Projektmanagement e. V.

  Sept 2017 - Mar 2018

  Project Management Specialist

  Successful completion of Project management Level D course according to the guidelines of German Association for Project Management (GPM / IPMA).

• 

  TherapySelect Dr. Frank Kischkel

  Dec 2017 - Feb 2018

  Project Manager

  Project planning for the company TherapySelect Dr. Frank Kischkel. Practical experience requirement of German Association for Project Management (GPM / IPMA) certified Project management specialist.

• 

  QIAGEN

  Jul 2018 - Nov 2022

  Project Manager / Corporate - PMO

  Leading Medical Device Development and registration projects.Supporting Project Managers in their project management activities e.g., planning, execution, budget, and resource management etc.Development of QIAGEN specific Project Management Process and SOPs.

• 

  Miltenyi Biotec

  Dec 2022 - now

  Project Manager

  Leading projects contributing to the GMP readiness, clinical trial and commercialization of gene therapy based drug products. Leading projects contributing to the commercialization of off-the-shelf Lentiviral vectors.